Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Article in Scientific Reports (January 2024)
The most recent citing publications are shown below. View all 118 publications that cite this research output on Dimensions.
Article in Scientific Reports (January 2024)
Preprint in bioRxiv (October 2023)
Article in International Journal of Molecular Sciences (September 2023)